Join Growin Stock Community!
Beta
Back to GEN.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

GEN Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for GEN's operating expenses in Q4'26 shows a total of $214M USD, comprising $104M in R&D expenses and $210M in SG&A expenses, reflecting a moderate increase from the previous quarter driven primarily by higher R&D spending. Over the period from Q1'24 to Q4'26, total operating expenses exhibited volatility with an overall upward trend, rising from $327M in Q1'24 to a peak of $480M in Q1'26 before stabilizing around $214M in Q4'26; R&D expenses declined initially from $90M to $77M through Q3'24, then rebounded steadily to $104M by Q4'26, while SG&A expenses fluctuated significantly, surging to $580M in Q2'24 and $371M in Q1'26 before dropping sharply to $210M in Q4'26, indicating potential cost optimization efforts in administrative functions.